SLC4A4 as a novel biomarker involved in immune system response and lung adenocarcinoma progression
SLC4A4 as a novel biomarker involved in immune system response and lung adenocarcinoma progression is a paper indexed in PICO Portal from OpenAlex.
How many citations does SLC4A4 as a novel biomarker involved in immune system response and lung adenocarcinoma progression have?
SLC4A4 as a novel biomarker involved in immune system response and lung adenocarcinoma progression has 4 citations in the OpenAlex counts PICO Portal stores.
When was SLC4A4 as a novel biomarker involved in immune system response and lung adenocarcinoma progression published?
SLC4A4 as a novel biomarker involved in immune system response and lung adenocarcinoma progression has 2024 year in the PICO Portal index.
What is the open-access status of SLC4A4 as a novel biomarker involved in immune system response and lung adenocarcinoma progression?
SLC4A4 as a novel biomarker involved in immune system response and lung adenocarcinoma progression has hybrid oa status in the PICO Portal index.
What is the DOI of SLC4A4 as a novel biomarker involved in immune system response and lung adenocarcinoma progression?
The DOI for SLC4A4 as a novel biomarker involved in immune system response and lung adenocarcinoma progression is on the source record.
What is the PMID of SLC4A4 as a novel biomarker involved in immune system response and lung adenocarcinoma progression?
The PMID for SLC4A4 as a novel biomarker involved in immune system response and lung adenocarcinoma progression is on the source record.
What is the OpenAlex record for SLC4A4 as a novel biomarker involved in immune system response and lung adenocarcinoma progression?
The OpenAlex for SLC4A4 as a novel biomarker involved in immune system response and lung adenocarcinoma progression is on the source record.